InvestorsHub Logo
Followers 77
Posts 3684
Boards Moderated 0
Alias Born 01/17/2003

Re: Umibe5690 post# 256304

Friday, 12/20/2019 12:22:52 AM

Friday, December 20, 2019 12:22:52 AM

Post# of 704475
They are already ready for the production of vax-l and can easily expand in modular increments. The thing is, they don't need a marketing team to sell this. So they don't need to partner with BP to get that. Hopefully, the work on the SAP has pushed them most of the way to where they need to get with the RAs for the applications for marketing approval. If that's the case I'm not sure what they need from a BP guy in terms of help with regulatory affairs.

They sure do need more capital. We'll see soon enough how much they raise themselves or if they go to BP partnership for that reason. The one big problem I see is that LP after working on this for years is hardly going to want to sell Direct for much less than she thinks it's worth as a possible franchise for treating all solid tumors, while I don't think BP is going to be willing to pay a large premium for Direct at this stage.

A partnership with any BP putting up a large amount of cash even if not in the billions would certainly boost investor confidence. It would be very nice if LP could at least swing a right-sized deal even if it doesn't involve selling the whole company at this point. It remains to be seen, all speculation at this point of course. I'm sure that LP is a very hard-nosed negotiator but does she really want to carry full responsibility for a few more years? My guess is that she probably is and has the confidence that she'll get more for NWBO a few years down the road than BP is willing to offer here. Just for a guess.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News